Objective To summarize clinical experience on the diagnosis and treatment for malignancy originating from the dacryocyst. Methods We retrospectively analyzed clinicopathological data from 12 cases that were diagnosed with malignancy originating from the dacryocyst by histopathological examination in our hospital from 2007 to 2017. Results Of the 12 cases with malignancy originating from the dacryocyst, 7 were male and 5 were female, with a mean age of 53 years (range, 4-81). Clinical manifestations included a mass in the dacryocyst area in 12 cases, epiphora in 9 cases, pyoid tears in 2 cases, bloody tears in 3 cases, and redness and swelling in the dacryocyst area in 2 cases. Lymphoma occurred in six cases, malignant melanoma in three cases, embryonal rhabdomyosarcoma in one case, and squamous cell carcinoma in two cases. Conclusions Misdiagnosis and missed diagnosis readily occur for malignancy originating from the dacryocyst because its clinical manifestations are diverse. For the suspected patients, it is necessary to perform related examinations. Individualized treatment should be adopted based on pathological types and specific conditions.
Introduction
The malignancy originating from the dacryocyst is rare and has various clinical manifestations. Most of malignancies from the dacryocyst exhibit epiphora, which is easily diagnosed as chronic dacryocystitis, delaying diagnosis and treatment. Pathological types of malignancy from the dacryocyst include squamous cell carcinoma, adenocarcinoma, lymphoma, malignant melanoma, rhabdomyosarcoma, and so on. The prognosis of dacryocyst malignancy is related to pathological type and staging, especially early diagnosis and early treatment. At present, there is no unified standard for the treatment of dacryocyst malignancy. Except surgical resection, the therapeutic effects of radiotherapy and chemotherapy on dacryocyst malignancy have been controversial [1] [2] [3] [4] [5] . The aim of this study was to further understand the clinical features, pathological types, treatment, and prognosis of dacryocyst malignancy by analysis of clinicopathological data from 12 cases.
Materials and methods
All study methods were approved by the Ethics Committee of the First Affiliated Hospital of Zhengzhou University. All the subjects enrolled into the study gave written informed consent to participate.
We retrospectively analyzed clinical symptoms, radiographic outcomes, histopathological sections, immunohistochemical staining, treatment, and prognosis in the 12 cases that were diagnosed with malignancy originating from the dacryocyst by histopathological examination in our hospital from 2007 to 2017.
Results

Clinical features
Of the 12 dacryocyst malignancy cases with a mean age of 53 years (range, 4-81), 7 with a mean age of 46 years were male and 5 with a mean age of 63 years were female. The dacryocyst malignancy occurred in the left eye of seven cases, and in the right eye of five cases. The shortest course of disease was 20 days and the longest was 3 years. All the 12 cases had a mass in the dacryocyst area. Epiphora occurred in nine cases. Of the nine cases, two also had pyoid tears and three also had malignant melanoma-caused bloody tears. One case with malignant melanoma had epistaxis and exophthalmos with outward displacement. Two cases with NK/T cell lymphoma had redness and swelling in the dacryocyst area, and were misdiagnosed as acute dacryocystitis, which did not respond to antibiotic treatment.
Radiographic outcomes
CT showed a mass in the dacryocyst area in all the 12 cases, nasolacrimal duct expansion in four cases, including two cases with lymphoma, one case with squamous cell carcinoma, and one case with malignant melanoma, bone destruction involving paranasal sinus and orbit in one case with malignant melanoma, and soft tissue swelling around the orbit in two cases with NK/T cell lymphoma.
Pathological characteristics
Of the 12 cases, 6 had lymphoma, including extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue in 2 cases, diffuse large B cell lymphoma in 2 cases, and extranodal NK/T cell lymphoma in 2 cases. Three cases had malignant melanoma, one case embryonal rhabdomyosarcoma, and two cases squamous cell carcinoma.
Treatment and prognosis
In the six cases with lymphoma, two with extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue received surgery followed by postoperative radiotherapy, and follow-up indicated no recurrence. Of the two cases with diffuse large B cell lymphoma, an 81-yearold female case refused chemoradiation after surgery, and died 1 year later; another 62-year-old male case received surgery and postoperative chemoradiation, and died 3 years later. Two cases with NK/T cell lymphoma received surgery and postoperative chemoradiation, and had no recurrence. In three cases with malignant melanoma, a 63-year-old female case with melanoma involving paranasal sinuses and orbit refused chemoradiation after surgery and died 6 months later; other two cases with malignant melanoma received surgery and postoperative radiotherapy, and in the two cases, one 60-year-old female case died 5 years later and another 49-year-old female case still survived. One 4-year-old child with embryonal rhabdomyosarcoma received surgery and postoperative chemoradiation and 2-year follow-up indicated no recurrence. Two cases with squamous cell carcinoma received surgery and postoperative radiotherapy; and in the two cases, one 61-year-old female case had no recurrence during 5-year follow-up and another 45-year-old male case had oral squamous cell carcinoma during the 5-year follow-up (Table 1) .
Discussion
The malignancy of the lacrimal sac is rare and commonly occurs in 50-60-year-old people. Its incident is not different in sex and races. The malignancy of the lacrimal sac is characterized by insidious onset and lack of specific clinical manifestation, so misdiagnosis and missed diagnosis easily occur and the duration from onset to medical consultation is usually long. In this study, seven cases were male and five were female without significant difference between sex, and with a mean age of 53 years (range, 4-81), which is consistent with the results in other reports [1] [2] [3] [4] [5] . The malignancy originating from lacrimal sac shows various clinical manifestations such as epiphora and pyorrhea in early stage; local mass in the dacryocyst area, invasion to nasal cavity and orbit, and local skin rupture due to tumor growth; and regional lymphadenopathy and systemic metastasis in advanced stage. In malignancy originating from dacryocyst, the most common clinical symptoms were swelling of lacrimal sac region and epiphora, which are readily diagnosed as chronic dacryocystitis because these symptoms are similar to the clinical symptoms of chronic dacryocystitis. The rare symptoms including bloody tears as well as redness and swelling in the dacryocyst area should be paid attention. In this study, two cases had redness and swelling in the dacryocyst area, which was similar to the symptoms of acute dacryocystitis, did not respond to antibiotics, and were finally diagnosed with extranodal NK/T cell lymphoma by pathological examination. The pathology of NK/T lymphoma is characterized by pleomorphic lymphocytic infiltration around blood vessels, tumor cell infiltration leads to necrosis and inflammation of local blood vessel. This easily misdiagnosed as inflammatory lesion. It is difficult to make a definite diagnosis when the sample site is too shallow or improper in pathological biopsy, so multiple pathological biopsies are required if necessary [6] . It has been reported that lymphoma originating from the dacryocyst commonly diffuse large B cell lymphoma (DLBCL) and extranodal marginal zone B cell lymphoma of mucosa-associated lymphoid tissue (MALT), while extranodal NK/T cell lymphoma (NK/T) is rare [7] [8] [9] . However, in this study, of the six cases with lymphoma, two had NK/T. Therefore, NK/T should not be neglected in the malignancy originating from dacryocyst, and the possibility of NK/T lymphoma should be considered in the cases that have dacryocystitissimilar symptoms and do not respond to antibiotics. Bloody tears may be related to rich blood supply of tumor and tumor growth into the dacryocyst cavity through dacryocyst epithelium [10] [11] [12] [13] . In this study, three cases with malignant melanoma all had bloody tears, so the case with bloody tears may have malignancy originating from dacryocysts, especially malignant melanoma.
In the patients with suspected dacryocyst malignancy, it is necessary to know their medical history, examine their eyes, and perform lacrimal passage irrigation and exploration. Nasal endoscopy can find whether there is a mass extending to the lower nasal cavity through the nasolacrimal duct. If a mass is found, biopsy is necessary. In body examination, we should pay attention to lymphadenopathy, especially the lymph node in head and neck. MRI can discriminate between cystic and solid lesions. MRI shows solid lesions as moderate signal intensity in T1-weighted sequence and low-signal intensity in T2-weighted image, while shows cystic lesions caused by dacryocystitis as highsignal intensity in T2-weighted image. Axial and coronal CT scans could determine the extent of lesions, relationship with surrounding tissues, and bone destruction. The malignancy originating from dacryocyst may grow into the nasolacrimal duct, leading to nasolacrimal duct expansion [14, 15] . If imaging examination shows nasolacrimal duct expansion, especially accompanied by bone destruction; a great deal of attention should be paid to the possibility of malignancy from dacryocyst. In this study, one case with malignant melanoma had bone destruction involving paranasal sinus and orbit, and died 6 months after surgery.
The main treatment methods for malignancy originating from dacryocyst include surgery, radiotherapy, and chemotherapy. For the malignant tumor confined to lacrimal sac, besides the mass, nasolacrimal duct and vicinal periosteum also should be removed during surgery. For most tumors with high malignancy, the resection scope should extend to nasal and orbital bones. For most malignant tumors invading the surrounding tissues, the mass is removed as thoroughly as possible in order to get the margins free from tumor cells. Postoperative radiotherapy can improve the local control rate and reduce tumor recurrence and metastasis rates [5, 7] . This study indicated that postoperative radiotherapy had a certain effect on the malignancy originating from dacryocyst, especially for MALT because two cases with MALT had no recurrence 108 and 60 months after surgery, respectively. The choice of chemotherapy is based on pathological types and stages. In recent years, the development of immunotherapy and biological target therapy has provided new options for the treatment of malignancy originating from dacryocyst.
Malignancy originating from dacryocyst is rare and there are no unified treatment protocols for it. This study indicated that the prognosis of malignancy originating from dacryocyst is closely associated with pathological types. Therefore, individualized treatment should be adopted based on pathological types, tumor stage, and specific conditions. It has been reported that MALT lymphoma is a low-grade malignant with a good prognosis, while DLBCL and NK/T cell lymphoma are high-grade malignant with a poor prognosis [6-9, 16, 17] . In this study, two cases with MALT had no recurrence 5 years after treatment, but two cases with DLBCL died within 5 years after treatment. Our results were consistent with the reports [6-9, 16, 17] . Therefore, we suggest that for MALT lymphoma confined to lacrimal sac, surgical resection combined with radiotherapy is adopted; for DLBCL and NK/T cell lymphoma, and advanced MALT lymphoma, surgical resection combined with chemoradiation is adopted. Dacryocyst melanoma, mucosa malignant melanoma, is characterized by strong invasion, easily recurrence and metastasis, and poor prognosis [10] [11] [12] [13] . This study also indicated poor prognosis of malignant melanoma because two cases died within 5 years after treatment in the three cases with malignant melanoma. Therefore, we suggest that for malignant melanoma, extended surgical resection combined with radiotherapy and immunotherapy is adopted. Comprehensive treatment can greatly improve the survival rate of cases with rhabdomyosarcoma although rhabdomyosarcoma is characterized by easily frequent recurrences and metastasis [18] . In this study, one case with rhabdomyosarcoma who was treated by surgical resection combined with chemoradiation, had no recurrence during 2-year follow-up, so we suggest that for rhabdomyosarcoma, surgical resection combined with chemoradiation is adopted. Squamous cell carcinoma in head and neck is characterized by local recurrence and lymphatic metastasis and is sensitive to radiotherapy [19] . In this study, one case with squamous cell carcinoma received surgical resection combined with radiotherapy; although he had no recurrence in his right eye, squamous cell carcinoma occurred in his oral cavity 5 years later. Therefore, we suggest that for squamous cell carcinoma confined to lacrimal sac, surgical resection combined with radiotherapy is adopted; for advanced squamous cell carcinoma, surgical resection combined with chemoradiation is adopted. Due to rare cases with malignancy originating from dacryocyst in clinics, it is necessary to further collect cases to summarize the experience of diagnosis and treatment.
Summary
What was known before:
• The malignancy originating from the dacryocyst is rare.
• Most of malignancy from the dacryocyst are easily diagnosed as chronic dacryocystitis.
What this study adds:
• NK/T should not be neglected in the malignancy originating from dacryocyst.
• The case with bloody tears may have malignancy originating from dacryocysts, especially malignant melanoma.
